The purpose of this randomized, multi-center, controlled, double-blind, parallel study is to evaluate the health and developmental outcomes of children fed a new infant formula and toddler drink through 24 months of age.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Enrollment
168
Ad libitum or as instructed by HCP, feeding period from enrollment to 12 months of age
16 fl oz per day as primary milk beverage; feeding period from 12 to 24 months of age
Ad libitum or as instructed by HCP, feeding period from enrollment to 12 months of age
Incidence of respiratory infection between study groups
Adverse event reports
Time frame: Study Day 1 to 6 Months of Age
Infection morbidity between study groups
Adverse event reports
Time frame: Study Day 1 to 24 Months of Age
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
16 fl oz per day as primary milk beverage; feeding period from 12 to 24 months of age
Ad libitum formula given up to 12 months of age if HM is supplemented
16 fl oz per day if weaned from HM feedings
Southeastern Pediatric Associates
Dothan, Alabama, United States
Eclipse Clinical Research
Tucson, Arizona, United States
The Children's Clinic of Jonesboro, P.A.
Jonesboro, Arkansas, United States
Applied Research Center of Arkansas
Little Rock, Arkansas, United States
Boeson Research 3266
Grand Junction, Colorado, United States
TOPAZ Clinical Research, Inc.
Apopka, Florida, United States
ASCLEPES Research Centers
Spring Hill, Florida, United States
Meridian Clinical Research 3259
Macon, Georgia, United States
Clinical Research Prime
Idaho Falls, Idaho, United States
Leavitt Clinical Research
Idaho Falls, Idaho, United States
...and 17 more locations